[1]
., L.C.S.S. et al. 2013. MEASUREMENT OF INTRAOCULAR PRESSURE FOLLOWING 0.05 ML (1.25MG) INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) TO DETERMINE THE RATIONALE OF USING POST-INJECTION IOP LOWERING MEDICATION: Measurement of Intraocular Pressure. Pakistan Armed Forces Medical Journal. 63, 1 (Mar. 2013), 4–8.